In mice, pharmacological inhibition of ENT1 as well as global and adipose-specific ablation enhanced BAT activity and counteracted diet-induced obesity, respectively. The gene discussed is SLC29A1; the disease is obesity due to melanocortin 4 receptor deficiency.